• PharmEdaily
• Syntekabio
• Panolos

SyntekaBio, Panolos Sign MOU on Next-Gen Multispecific Antibodies

• 송영두
• 2025.12.05
• 오전 09:55

AimedBio Emerges as a KOSDAQ Dark Horse with W2.8tr Market Cap on Debut Day [K-Bio Pulse]

• 임정요
• 2025.12.05
• 오전 07:50

Samsung Epis Holdings rebounds on new drug IND filing [K-Bio Pulse]

• 임정요
• 2025.12.04
• 오전 08:15

Celltrion's Xolair biosimilar nabs US approval for 300mg PFS version

• 임정요
• 2025.12.03
• 오전 10:29

• pharmEdaily

Abion Surges on Bonus Stock Plan…SBioMedics Gains 19%[K-bio pulse]

• 김진수
• 2025.12.03
• 오전 08:15

• Korea’sbiotech
• HanAllBiopharma
• Peptron
• phamed

Trust Dividend for HanAll, Valuation Penalty for Peptron·Caregen[K-Bio Pulse]

• 유진희
• 2025.12.02
• 오전 08:15

• Kbiopulse
• PharmEdaily

Samyang Biopharm, T&R Biofab Surge…Peptron Volatile on Lilly Catalyst[K-Bio Pulse]

• 김새미
• 2025.12.01
• 오전 08:10

Huons Reports Safety and Tolerability Results of New Drug for Dry Eye Syndrome in Phase 1 Clinica...

• 신민준
• 2025.11.28
• 오후 02:36

• Celltrion
• PharmEdaily
• biosimilar

Celltrion Receives Canadian Approval for Eylea Biosimilar ‘Eydenzelt’

• 김새미
• 2025.11.28
• 오전 10:16

Vigencell Soars on Trial Win; Foreign Buying Lifts Nextbiomedical [K-Bio Pulse]

• 석지헌
• 2025.11.28
• 오전 09:18